Загрузка...
Where do we go from here? Reappraising the data on anticoagulation in pulmonary arterial hypertension
The use of anticoagulation as part of the treatment regimen in pulmonary arterial hypertension (PAH) remains a topic of debate. A recently published analysis of anticoagulation use in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL) study offers conflicting conclusions re...
Сохранить в:
| Опубликовано в: : | J Thorac Dis |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
AME Publishing Company
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4842822/ https://ncbi.nlm.nih.gov/pubmed/27162687 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2016.03.67 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|